HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Clinical In Vivo Gene Therapy News & Announcements
Displaying announcements from the past three years.
1 - 16 of 16
Published on Dec 30, 2024 in Cornerstone Blog
We tallied up the most popular Cornerstone blog stories of 2024 based on data across our CHOP Research social media platforms.
Published on Sep 27, 2024 in Cornerstone Blog
Symposium highlights AAV gene therapy best practices for children, CHOP researchers develop novel nanopore platform, and more In the News
Published on Sep 19, 2024 in Cornerstone Blog
CHOP researchers developed a factor VIII variant that led to safe and long-lasting therapeutic results in preclinical models.
Published on Jul 29, 2024 in Cornerstone Blog
The CGTC helps to accelerate clinical trials, training, and research, enabling CHOP to remain a global leader in the space.
Published on Jun 20, 2024 in Cornerstone Blog
Using CRISPR/Cas9 gene editing in an early-stage clinical trial, researchers showed improved vision for a severe inherited form of blindness.
Published on May 29, 2024 in Cornerstone Blog
Decades ago, Katherine A. High, MD, and colleagues began an unprecedented journey to develop a new kind of treatment for hemophilia B.
Published on May 21, 2024 in Cornerstone Blog
As the administrative manager of the Clinical In Vivo Gene Therapy (CIGT) group, Sarah McCague manages a team of CRCs who are critical liaisons between families and the hospital.
Published on Jan 23, 2024 in Cornerstone Blog
This milestone represents an important step in treatment options for patients with hereditary hearing loss caused by genetic mutations.
Published on Oct 10, 2023 in Cornerstone Blog
CHOP's NoT Bleeding Program will conduct clinical trials to develop the next generation of therapeutics for hemophilia A, B, and other bleeding disorders.
Published on Aug 31, 2023 in Cornerstone Blog
Children’s Hospital of Philadelphia is the lead study site for the development of a gene therapy for multiple sulfatase deficiency.
Published on Aug 29, 2023 in Cornerstone Blog
The Clinical In Vivo Gene Therapy group supports CHOP’s continued leadership in the in vivo gene therapy space.
Published on Jun 26, 2023 in Cornerstone Blog
The FDA has granted accelerated approval of the first gene therapy for Duchenne muscular dystrophy — a major win for those affected by the debilitating disorder, CHOP experts say.
Published on May 19, 2022 in Cornerstone Blog
The Ninth Annual CRC RE@CH Awards celebrated all clinical research staff at CHOP for their contributions to the research community with a spotlight on two honorees.
Published on Nov 19, 2021 in Cornerstone Blog
Dr. Lindsey George and colleagues report safe and sustained expression following hemophilia A gene therapy.
Published on May 12, 2019 in Cornerstone Blog
We’re celebrating our research hero, Jaxson, and his super mom, Megan, this Mother’s Day. Thank you for making time for science.
Published on Oct 8, 2018 in Cornerstone Blog
An infographic and article look at the science behind gene therapy, challenges faced by the field, and the road ahead.